F8394-201: A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations
- Title
- A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations
- Principal Investigator
- Aulakh, Sonikpreet
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Brain Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Nina Moore, RN
- Research Specialist
- Phone: +1 304-293-2991
- Email: nina.moore@hsc.wvu.edu